 Source: Swayampakula Ramakanth 1423 Because of the green light from the U.S. Food and Drug Administration, H.C. Wainwright Co. raised its target price on the developer of this drug, according to a recent report. Vericel Corp.s VCEL:NASDAQ NexoBrid, a product that removes nonviable burn tissue, was recently approved and given a wider label than expected ...... 